BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9142246)

  • 1. The role of alloantigen-independent factors in transplant arteriosclerosis.
    Kouwenhoven EA; Marquet RL; Bonthuis F; IJzermans JN; de Bruin RW
    Transplant Proc; 1997 May; 29(3):1721-2. PubMed ID: 9142246
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerated arteriosclerosis in aortic grafts: a role for activated complement and IgM antibody in early lesion development.
    Geerling RA; Ansari AA; LaFond-Walker AM; Baumgartner WA; Herskowitz A
    Transplant Proc; 1998 Jun; 30(4):1017-9. PubMed ID: 9636411
    [No Abstract]   [Full Text] [Related]  

  • 3. Accelerated arteriosclerosis in aortic grafts: a role for cytokines in progressive intimal lesion development.
    Geerling RA; Ansari AA; LaFond-Walker AM; Baumgartner WA; Wesselingh S; Herskowitz A
    Transplant Proc; 1998 Jun; 30(4):946-7. PubMed ID: 9636381
    [No Abstract]   [Full Text] [Related]  

  • 4. Alloimmune response may be involved in neointimal hyperplasia in cryopreserved aortic allografts.
    Osako M; Otani H; Yamamura T; Nakao Y; Hattori R; Omiya H; Fujii H; Tanaka K; Imamura H
    Transplant Proc; 2001 Jun; 33(4):2566-70. PubMed ID: 11406250
    [No Abstract]   [Full Text] [Related]  

  • 5. Medial cell apoptosis precedes the development of intimal hyperplasia after transient allogeneic exposure in a rat aortic allograft model of chronic rejection.
    Hare GM; Lee TD; Jordan JL; Hirsch GM
    Transplant Proc; 1999; 31(1-2):1384-5. PubMed ID: 10083612
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC.
    Bruning JH; Persoons M; Lemström K; Stals FS; De Clercq E; Bruggeman CA
    Transpl Int; 1994; 7 Suppl 1():S365-70. PubMed ID: 11271253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SDZ RAD on transplant arteriosclerosis in the rat aortic model.
    Cole OJ; Shehata M; Rigg KM
    Transplant Proc; 1998 Aug; 30(5):2200-3. PubMed ID: 9723440
    [No Abstract]   [Full Text] [Related]  

  • 9. Pravastatin decreases cold ischemia--but not alloantigen-dependent transplant arteriosclerosis.
    Domínguez J; Schultz M
    Transplant Proc; 2003 Dec; 35(8):3121-4. PubMed ID: 14697993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease therapy alleviates allograft arteriosclerosis in rats.
    Gaciong Z; Paczek L; Bojakowski K; Socha K; Wiśniewski M; Lietz K; Lao M; Heidland A
    Transplant Proc; 1996 Dec; 28(6):3439-40. PubMed ID: 8962341
    [No Abstract]   [Full Text] [Related]  

  • 11. CD8+ cytotoxic T lymphocytes are involved in inducing medial cell dropout via apoptosis in mouse aortic allografts.
    O'Neill JL; Lee TD; Hirsch GM
    Transplant Proc; 1999; 31(1-2):865-6. PubMed ID: 10083377
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of angiopeptin on transplant arteriosclerosis in the rat.
    Akyürek ML; Wanders A; Aurivillius M; Larsson E; Funa K; Fellström BC
    Transpl Int; 1995; 8(2):103-10. PubMed ID: 7766291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local administration of estrogen inhibits transplant arteriosclerosis in rat aorta accelerated by topical exposure to IGF-I.
    Motomura N; Lou H; Hong M; Tsutsumi Y; Mayumi T; Foegh ML
    Transplant Proc; 1997; 29(1-2):1118-20. PubMed ID: 9123226
    [No Abstract]   [Full Text] [Related]  

  • 14. Ischemia-induced transplant arteriosclerosis in the rat.
    Wanders A; Akyürek ML; Waltenberger J; Ren ZP; Stafberg C; Funa K; Larsson E; Fellström B
    Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):145-55. PubMed ID: 7749811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated CD40Ig expression attenuates chronic vascular rejection lesions in an aorta allotransplantation model.
    Mathieu P; Guillot C; Gerdes C; Buzelin F; Lowenstein P; Castro M; Soulillou JP; Anegon I
    Transplant Proc; 2002 May; 34(3):743-4. PubMed ID: 12034168
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of graft arteriosclerosis after allogeneic fresh and cryopreserved aortic transplantation in the rat.
    Gabriel M; Fändrich F
    Transplant Proc; 2002 Mar; 34(2):711-2. PubMed ID: 12009674
    [No Abstract]   [Full Text] [Related]  

  • 17. Aging and transplant arteriosclerosis in absence of alloreactivity and immunosuppressive drugs in a rat aortic model: recipient age's contribution.
    Calfa M; Aïtouche A; Vazquez-Padron RI; Gay-Rabinstein C; Lasko D; Badell J; Farji A; El-Haddad A; Liotta C; Louis LB; Simmonds A; Pestana IA; Pang M; Li S; Pham SM
    Transplantation; 2005 Jun; 79(12):1683-90. PubMed ID: 15973169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The change of immunosuppressive effect of X-irradiation after transplant period for aortic transplantation in rat.
    Nagashima N; Shalabi A; Ogawa N; Koyama I; Burdick JF
    Transplant Proc; 2002 Nov; 34(7):2884-6. PubMed ID: 12431644
    [No Abstract]   [Full Text] [Related]  

  • 19. Recipient cells form the intimal proliferative lesion in the rat aortic model of allograft arteriosclerosis.
    Johnson P; Carpenter M; Hirsch G; Lee T
    Am J Transplant; 2002 Mar; 2(3):207-14. PubMed ID: 12096782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis.
    Pham SM; Shears LL; Kawaharada N; Li S; Venkataramanan R; Sehgal S
    Transplant Proc; 1998 Jun; 30(4):953-4. PubMed ID: 9636385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.